chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within less than 1 minute of administering 2nd vaccine which was Gardasil the patient began to lean forward. She was sitting on an exam table. Patient was speaking and continued to lean more forward she would later tell me that her vision was becoming blurred but at that time she did not voice this to the clinic staff. She continued to slump forward then passed out. Nurse was able to hook her arm and guide her to the floor. Her arms /shoulder area began to have jerking movements, then her body/lower extremites jerked. We began to tap her chest to get her to wake up. She woke as quickly as she went down but was disoriented. She became reoriented quickly. We had her stay lying on the floor for awhile then began to bring her to a sitting position which she became pale again but did not pass out. She left the clinic fine. No other injuries. Did not hit head when she pased out. I called the parent 2 weeks later and mother of patient reports she is fine. This was her 2nd dose of Gardasil. 1st dose Gardasil on 20 Sep 2010.
Information has been received from a physician concerning a female who on 06-JUN-2007 intramuscularly with a 0.5 ml dose of Gardasil. On 06-JUN-2007, the patient experienced significant pain and swelling at the injection site. The patient sought unspecified medical attention. At the time of the report, the patient was recovering. Additional information has been requested.
Fainted on 10.25.2021 Fever, Body aches  10.23 + 10.24. Extreme menstrual cramps 10.24 10.25 - present weakness - unable to continue running -(school sport - xc) (Patient never previously  vaccinated)
adverse effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (adverse effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ADVERSE EVENT (adverse effects). At the time of the report, ADVERSE EVENT (adverse effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  Treatment medications were not reported.
I experienced abdominal pain that radiated out to the right side. I thought it was appendicitis. I had 36 hours of pain and then went to ER. See medical test notes. Had a doctor visit with physician on the 8th.
I received my vaccine and in 24 hours my arm was red and felt hot. The pain went down my arm and across my chest. This lasted about a week. I took TYLENOL or ADVIL to help with the pain.
diarrhea 1-2x day (loose stool); t99; rash; fussy;
This spontaneous report was received from a physician, concerning a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 19-FEB-2018, the patient was inadvertently administered with a dose of ZOSTAVAX 19400 PFU, for prophylaxis, by the intramuscular route (anatomical location was not reported). The product lot number was reported as M020938 with expiration date on 31-JUL-2018. Lot number M020938 is an invalid lot number for Zoster Vaccine Live.
Pt learned shortly after receiving her COVID vaccine that she has a current COVID infection, which is a contraindication to receiving the vaccine. She did not have an allergic reaction and current has symptoms presumed attributable to COVID only
"bump" at injection site; This spontaneous report was received from a pharmacist and refers to a 20-year-old female patient. The patient's concurrent conditions, medical histories, concomitant medications, drugs reactions or allergies were not provided.  On an unknown date (reported as last week), the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), intramuscularly (dose, strength, lot # and expiration date were not provided) for prophylaxis. The patient complained of a "bump" at injection site a few days after receiving hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9). The outcome of the event was unknown.  The causal relationship between "bump" at injection site and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) was not provided.
10/5/2021 0300: woke up with severe vice-like headache, not responsive to Tylenol.   10/5/2021 0900: Severe vertigo, could not walk or move without assistance for approx 4 days.  Periodic vomiting, dry heaving,  nausea and lightheadedness.   Headache persistent over the next 2 weeks, was manageable with Tylenol every 4-6 hours. Developed dry cough, worse at night  Vertigo less severe after four days but still unsteady and unable to work, drive, cook, as vertigo spells were frequent and often accompanied with dry heaving, nausea and lightheadedness.   After three weeks, vertigo very infrequent. Experiencing fatigue, and continue to dry heave and dry cough has not improved.
Information gathered from ER report. Pt. c/o headache, facial swelling and vomiting X1.
The physician reported her niece spit out a dose of ROTATEQ; The physician reported her niece spit out a dose of ROTATEQ; No adverse effects were reported.; This spontaneous report was received from a physician referring to her niece a female patient of unknown age. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.  On an unknown date, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent(ROTATEQ) per oral route (strength, dose, frequency, anatomical location, lot # and expiration date were unknown) for prophylaxis. The physician reported her niece spit out a dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) on an unspecified date. No adverse effects were reported.        At the time of the report, the outcome of infantile spitting up, was unknown. The physician did not mention the causality assessment between the event and Rotavirus Vaccine, Live, Oral, Pentavalent(ROTATEQ).
This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 67-year-old female patient who received SHINGRIX (batch number 759E9, expiry date 25th April 2020) for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of injection site pain (1st dose administered on 15th March 2018, refer case US2018GSK116018) and Shingles vaccine. Concomitant products included paroxetine hydrochloride (Paroxetine), atorvastatin calcium (Atorvastatin), acetylsalicylic acid (Aspirin), ezetimibe and calcium + ergocalciferol (Calcium Plus D). In June 2018, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. In June 2018, 1 day after receiving SHINGRIX, the patient experienced injection site swelling, injection site erythema, injection site itching, injection site inflammation and fatigue. In June 2018, the outcome of the injection site swelling, injection site erythema, injection site itching, injection site inflammation and fatigue were recovered/resolved. The reporter considered the injection site swelling, injection site erythema, injection site itching, injection site inflammation and fatigue to be related to SHINGRIX. Additional information was reported as follows: The patient took multi vitamins as a concomitant medication. The patient was vaccinated with the 2nd dose of SHINGRIX on 15th June 2018 or 16th June 2018. The patient reported that she received the SHINGRIX vaccine and the following day experienced swelling, redness, and itching at the injection site, although the events occured at the injection site but did extend out to the deltoid. She also experienced fatigue which started a day after the injection, however her fatigue had resolved. The patient believed that the vaccine given by subcutaneous route instead of intramuscular, because of the events experienced by the patient but healthcare professional stated that he administered the vaccine by intramuscular route.  At the time of reporting, it had been a week since the patient received her 2nd dose and she was almost back to normal. This case was linked to case US2018GSK116018 (1st dose), reporter by the same reporter for the same patient. The case US2018GSK112091, was identified as a duplicate case for case US2018111419, so all the information from case US2018GSK112091 was retained in case US2018111419.
Itchy, swollen, and hard welt at the injection site. I think this reaction is referred to as Covid Arm.
1/4/21(day of vaccine)-approximately 1 hour later, irregular heart beats, "skipped beats" approximately every 10 seconds, decreasing in frequency over the next few hours, but persisting 2 weeks later. Appointment scheduled tomorrow ((1/20/21) with cardiologist.  1/11/21 (day 7 post vaccine)-vaccine site began to itch and induration began 1/12/21 (day 8 post vaccine)-marked induration, well demarcated redness, warmth and mild tenderness around vaccine site, measuring 8.5 cm x 5.5 cm. Rx with advil 400 mg and icepacks which help, but local reaction persisted approximately 5 days 1/14/21(day 10 post vaccine)-site still red and swollen, but starting to fade. Sneezing and rhinitis begins in PM 1/15/21 (day 11-continued..
pt recv vax & devel a high fever which lasted 3wk;the medical assistant reported two other pt;
allergic reaction at my eyes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EYE ALLERGY (non-serious), outcome "unknown", described as "allergic reaction at my eyes". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt received 1st dose Covid vaccine at 4:28pm on 6/19/21. During observation, patient reported a skin rash/itchiness  on the right side of neck and swelling of the tip of her tongue. Two capsules of Benadryl 25mg were given to patient. She consented to leave afterwards.
back itching; headache behind left eye; nausea; This spontaneous case was reported by a physician and describes the occurrence of PRURITUS (back itching), HEADACHE (headache behind left eye) and NAUSEA (nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PRURITUS (back itching), HEADACHE (headache behind left eye) and NAUSEA (nausea). At the time of the report, PRURITUS (back itching), HEADACHE (headache behind left eye) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not provided. Concomitant medications were not provided.
pt recv vax 7AUG96 & 8AUG96 pt exp shoulder, neck, & head pain;
09/04/2021 I had 2nd dose of Pfizer Vaccine, then 10/04/2021 I started have Urticarica,  At beginning not much, then developed more and more all over the body, every evening, my GP advised me to take  one tablet 180mg Telfast per day. but not working well, then suggested me to take one Tablet BD, then feels better now, but still have it every evening. need to take one Telfast every day.
PHarmacist gave the vaccine too low and almost behind the patient's arm. Patient came into pharmacy today 3/7 after getting shingrix on 3/5. Showed where the vaccine was given and described how the vaccine was given.  Patient was concern about getting the benefits of the vaccine and also the rxn of red rash stiff and warm to touch. suggested she place ice on the rxn and drink a lot of water
This spontaneous report as received from a pharmacist refers to a female patient of unknown age with diabetes. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, route of administration, lot number, expiration date were not reported). Concomitant therapies included NORCO and BYDUREON. On an unknown date, the patient experienced "full blown" case of shingles after ZOSTAVAX and postherpetic neuropathic pain. The patient sought medical attention - contacted pharmacist. VALTREX was given for treatment for the events. The outcome of "full blown" case of shingles and postherpetic neuropathic pain was reported as not recovered. Relatedness between the events and vaccination with ZOSTAVAX was not reported. Additional information has been requested.
sever itchy on palms, fingers, in between fingers, foot, forehead, side of right thigh, right side  cheek on face , eye lashes  NO RASH, NO REDNESS (other than where i scratched)  took benadryl an hour and a half after intitial problem  with in 30 minutes itchiness subsided but not totally gone
vaccine given 6 days post expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided. No treatment information was provided.   This case was linked to MOD-2021-395985 (Patient Link).
15MAY98 father called described rash little pimples scattered over body described 1 fluid filled no fever no other sx;noted 11 lesions;
Throat swelling and chronic cough for over half an hour, hives during coughing episode.  Nauseated feeling, loss of voice, shortness of breath.  Voice returned next day.  Scratchy throat for three days.  No treatment sought.
He received the second dose 04/29/21, 12 hours later developed fever/chills which resolved 24 later. 05/08/21- while at work (he is a line cook) he experienced a severe episode of vertigo and dizziness to the point he felt like he was going to pass out. He sat down for a while until he felt like he could drive himself home.  Once home took a shower and went to sleep.  05/09/21- Waking up the next day the dizziness has returned. (no vertigo)  He went to an urgent care where they prescribed a steroid and told him to see a Neurologist.      05/11/21-With the dizziness and sometimes having headaches before the dizzy spells continuing went to his Primary Care Doctor.   When he had the spells he would have to sit /lie down for several hours to feel better, but when he got up again he would experience a headache and the dizziness would return              usually an hour after getting up.   05/15/21-After completing the steroid dose and still experiencing the dizziness when usually standing longer than an hour, he went back to the urgent care and got prescribed more steroids.  05/17/21- Still experiencing the above went to an ENT doctor. He prescribed a higher dose of steroids and added Afrin, Flonase and Sudafed.  05/27/21-Went back to the ENT doctor because none of the meds made a difference with the symptoms he was experiencing. Stopped all meds and ordered a VNG. 06/10/21-Still experiencing the above symptoms had a MRI done- WNL 06/11/21- Had an appointment with another ENT doctor who specializes in vestibular disorders who ordered PT. Ordered additional tests. 06/18/21- PT starts 2x a week 06/25/21- VNG done-WNL  07/21/21-The headaches he was having before the dizzy spell have stopped but still having dizziness 4 to 5 times a day either brought on by moving his head to fast or doing housework ( ie. Vacuuming) longer than a hour. He can resolve them by lying down for a couple of hours. VEMP test done-WNL. VHIP test done-WNL. Rotational Chair test done- noted that the right inner ear was not functioning properly. Ordered additional PT.  9/23/2021 Continues to have episodes of dizziness to this day
Soreness in upper shoulder area and tender since 11-1-18,  patient notices it more when he does outside work.
pt recv vax & v/o dizziness, vomiting, rt arm pain, & fever;also states pt had surgery to site were vaccine was given;
Information has been received from a female consumer concerning her 18 year old daughter with no drug reactions/allergies and asthma and a history of mononucleosis (June 2009) who in August 2009, was vaccinated with her first dose of GARDASIL. Concomitant therapy included ALBUTEROL and ADVAIR. The consumer reported that on 04-SEP-2009, the patient developed "flu like symptoms" while she was at college. The patient was evaluated at the student health center and was diagnosed with "flu". The patient had the following symptoms, cough, sore throat and intermittent fever as high as 102.3F persisted. The patient came home from college on 27-OCT-2009 and was evaluated by the physician who recommended her to take multivitamins and vitamin C. On 11-NOV-2009, the patient was examined in a follow-up visit. A "strep test", "flu swab" and a "mono" test were performed which were negative. In addition, a complete blood count was performed and revealed anemia. At the time of the report, the patient had not recovered. Additional information has been requested.
Information has been received via the internet from a 24 year old female consumer with no history of seizures who was vaccinated with the third dose of GARDASIL in June 2007. In August 2007 the patient was hospitalized due to back problems. It was reported that "the following day", the patient experienced seizures (it was also reported that the onset date of back pain and seizures was in June 2007). The patient stated she experienced the following "preliminary symptoms: left eye weakens, strong pain in left side of the head, tremors and no feeling in face etc." After several days of seizures they disappear for several months and then reoccur. The patient stated that she had referred to a neurologist who did not know how to help her. The patient visited an epilepsy clinic where she was told that it was all in her mind because all the tests came positive. The outcome of the back pain was unknown and at the time of this report the patient had not recovered from the seizures. The reporter felt that the seizures were related to therapy with GARDASIL. Upon internal review seizures were considered to be an Other Medical Event. Additional information is not expected.
The morning after receiving the injection (15 hours after ) I experienced fatigue and soreness at the injection site and overall body aches.  I took two  Aleve but it didn't seem to help much. That evening I developed a fever of 102 . I took two more Aleve and went to bed. This morning my fever and general body aches were gone but there was still pain at the injection site and pain in my armpit area on the left side.  Now, 50 hours after the injection, there is still pain and tenderness at the injection site and  in my left armpit area .
Information has been received from a healthcare worker referring to a patient of unknown age and gender. The patient's medical history was not reported. On 27-APR-2015 the patient was received improperly stored VARIVAX (Merck) (lot #K007979, dose and route unknown). Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
Abscess and tissue necrosis at the injection site; Abscess and tissue necrosis at the injection site; Scarred; A spontaneous report was received from a nurse who is a 58-year-old, male, patient who received Moderna's COVID-19 vaccine (mRNA-1273) and developed an abscess and tissue necrosis at the injection site and scarred.  The patient's medical history was not provided. No concomitant product use was reported.  On 29 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011J20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   Approximately 6 to 7 days after the patient received the Moderna COVID-19 vaccine, the patient had an abscess and tissue necrosis at the injection site. The patient did not require hospitalization and self-treated it with polysporin.   On 20 Dec 2020, the patient reported the reaction had not resolved and was now scarred.   Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events, abscess and tissue necrosis at the injection site and scarred, were considered not resolved.; Reporter's Comments: This case concerns a 58 year-old, male patient, who experienced events of an abscess and tissue necrosis at the injection site and scarred. The events occurred 6 days after the first and last dose of mRNA-1273 vaccine administration. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded and the events are assessed as possibly related.
Delayed reaction on day 8 following injection that was into boney shoulder socket (not into muscle). Painful, Swollen, red itchy area 5? x 2?. This adverse reaction continues today- day 9.
tired; sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 81 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "tired"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm".  The lot number for bnt162b2 was not provided and will be requested during follow up.
My daughter tested positive on July 3, 2022, I decided to take a home COVID-19 test but did not wait for the test. My wife called and told me that test was a slight positive. I went to the testing sight and had a PCR COVID-19 test, it came back positive. I came home had congestion, extreme fatigue. dizzy, it felt like I had a sinus cold. I called my doctor and he prescribed Paxlovid that I took them as soon as I picked them up. My doctor sent a nurse to our home who gave us IV fluids, IV supplements. I am still testing positive, I'm still feeling a little fatigue and a little weird.